Breast Cancer Res Treat
Antineoplastic Agents, HormonalBreast NeoplasmsCarcinoma, Ductal, Breast
Dr. John T. Cole, MD
NPI1518925916PAC ID4688694631
- Medicare services, 2024
- 325
- Medicare patients, 2024
- 179
- Part D claims, 2024
- 1,267
- Publications
- 8
- Clinical trials
- 10
- Practice address
- 1516 Jefferson Hwy, New Orleans, LA 70121
- Practice phone
- Call (504) 842-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Cole's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John T. Cole is a hematologist and oncologist in New Orleans, Louisiana
Dr. Cole practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.
Dr. Cole's NPI, 1518925916, was assigned on May 3, 2006. Dr. Cole graduated from Louisiana State University School of Medicine in New Orleans in 1981. Dr. Cole holds Louisiana license MD.016169.
NPI and contact details
- NPI
- 1518925916NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4688694631
- NPI enumeration date
- May 3, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (504) 842-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. John T. Cole practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana
Dr. Cole's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.
- Ochsner Medical Center - New Orleans1516 Jefferson Hwy, New Orleans, LA 70121 · Jefferson ParishPhone(504) 842-3000
Source: Dmand AI Affiliation Data
Dr. John T. Cole is affiliated with 3 sites of care and 2 medical groups
Dr. Cole's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. Dr. Cole is also affiliated with Touro Infirmary. The medical group on file is Ochsner Health. Dmand AI also links Dr. Cole to 1 more hospital and 1 medical group, each named with a free account.
Touro InfirmaryOchsner Health1 hospitalName with a free account1 medical groupName with a free account
See all 5 affiliations for Dr. ColeSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. John T. Cole's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ochsner Medical Center - New Orleans | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Cole practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Ochsner Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John T. Cole is one of 171 hematologists and oncologists in Louisiana
Hematology and oncology is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cole is licensed in Louisiana.
Specialties and state licenses
- Hematology and oncology, LouisianaPrimary
Hematologists and oncologists near Dr. Cole
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
171hematologists and oncologists in Louisiana41hematologists and oncologists in New Orleans22hematologists and oncologists at Ochsner Medical Center - New Orleans
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John T. Cole billed Medicare for 325 services in 2024
CMS data shows 325 Medicare services from Dr. Cole across 2 procedure codes in 2024, all of them office visits, for 179 Medicare patients. Medicare paid $17,157 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2024325
Medicare patients179
Paid by Medicare$17,157
Procedure codes2
Dr. Cole's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3802024: 32514%
Dr. Cole compared with the Louisiana median for hematologists and oncologists, 2024
- Dr. Cole
- Louisiana median
- Medicare services
- 325vs 55241% below
- Medicare patients
- 179vs 184Close to median
- Part D claims
- 1,035vs 60372% above
Medians across 174 hematologists and oncologists in Louisiana with Dmand AI profiles that report each measure.
Dr. Cole's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Cole?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Cole and other hematologists and oncologists in Louisiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John T. Cole treated 179 Medicare patients in 2024, average age 74
CMS counts 179 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have cancer, and 73% have high cholesterol. Their average risk score is 1.48, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 72, with 91% women.
Medicare patients, 2024179
Average age74
Average risk score1.48
Dr. Cole's Medicare patients by age, 2024
Dr. Cole's Medicare patients by sex, 2024
- Women16492%
- Men158%
Chronic conditions among Dr. Cole's Medicare patients, 2024
- Cancer75%
- High cholesterol73%
- High blood pressure65%
- Arthritis44%
- Osteoporosis30%
- Mood disorders27%
- Anxiety23%
- Chronic kidney disease22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Cole's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women91%
- Men9%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. John T. Cole wrote 1,267 Medicare Part D claims in 2024
In 2024, Dr. Cole wrote 1,267 Medicare Part D claims for 271 patients. 92% of them were for generic drugs. CMS names the drug for 1,035 of them, across 21 drugs with 11 or more claims each, at $778,406 in total drug cost. In 2023, CMS named 1,195 claims across 27 drugs.
Part D claims, 20241,267
Drugs named by CMS21
Total drug cost$778,406
Part D patients271
Dr. Cole's Part D claims by kind of drug, 2024
- Generic1,161 claims92%
- Brand-name and other106 claims8%
Dr. Cole's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Cole's Part D claims, 2024
- Opioids3%42 of 1,267 claims
- Antibiotics1%14 of 1,267 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1952024: 1,03513%
Drugs named by CMS: 21 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. John T. Cole offers telehealth to Medicare patients
Dr. Cole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cole as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Cole by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John T. Cole has 8 publications on record
Dmand AI links 8 papers to Dr. Cole, published from 2012 to 2022. 2012 was the busiest year, with 2. Dr. Cole has published most often in Ochsner J. Dr. Cole's most frequent co-authors are Jessica Marie Boyce, MD, Fady Farag, MD and Yvonne E. Gilliland, MD.
Papers8
Years published2012 to 2022
Dr. Cole's papers by year, 2012 to 2022
Dr. Cole's most frequent co-authors
- Jessica Marie Boyce, MD1 shared paper
- Fady Farag, MD1 shared paper
- Yvonne E. Gilliland, MD1 shared paper
Recent publications by Dr. Cole
AdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsChoriocarcinoma
Cell CommunicationCell Line, TumorChemokine CXCL12
See who Dr. Cole researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cole works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. John T. Cole has worked on 10 clinical trials
Dmand AI links Dr. Cole to 10 clinical trials, 5 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Breast Neoplasms and Breast Diseases. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Cole by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Cole's trials
- Breast Carcinoma In Situ
- Breast Neoplasms
- Breast Diseases
- Carcinoma, Intraductal, Noninfiltrating
- Cardiotoxicity
Investigators on the most trials with Dr. Cole
- Wajeeha Abdul Razaq, MD6 shared trials
- Olwen M. Hahn, MD5 shared trials
- Isoken Koko, MD5 shared trials
Recent clinical trials with Dr. Cole
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study (opens in a new tab)
Active, not recruiting
COVID-19Pneumonia, Viral
Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent (opens in a new tab)
Active, not recruiting
Rectal NeoplasmsColonic Neoplasms
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy (opens in a new tab)
Active, not recruitingPhase 2
DocetaxelNab-paclitaxelPaclitaxel
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer (opens in a new tab)
RecruitingPhase 3
CardiotoxicityDrug-Related Side Effects and Adverse ReactionsCarvedilol
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Breast NeoplasmsBreast DiseasesPalbociclibAnastrozoleExemestane
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. John T. Cole received $1,786 in industry payments from 2016 to 2025
CMS Open Payments shows 34 general payments to Dr. Cole from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $439.
General payments to Dr. Cole by program year, 2016 to 2025
General payments to Dr. Cole by kind, 2016 to 2025
$1.8Kin total
- Food and beverage$1,67394%
- Education$1136%
Companies that paid Dr. Cole the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. John T. Cole graduated from Louisiana State University School of Medicine in New Orleans
Dr. Cole graduated from Louisiana State University School of Medicine in New Orleans in 1981.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. John T. Cole's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John T. Cole
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John T. Cole's NPI number?
Dr. John T. Cole's NPI number is 1518925916. It was assigned on May 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. John T. Cole?
Dr. John T. Cole is a hematologist and oncologist in New Orleans, Louisiana. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. John T. Cole practice?
Dr. Cole practices at 1516 Jefferson Hwy, New Orleans, LA 70121. Dr. Cole's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. Dmand AI also links Dr. Cole to 1 hospital and 1 medical group.
What is Dr. John T. Cole's office phone number?
The practice phone on file for Dr. Cole is (504) 842-3000.
What is Dr. John T. Cole's medical license number?
Dr. Cole holds Louisiana license MD.016169.
Which hospitals is Dr. John T. Cole affiliated with?
Dr. Cole practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana. Dr. Cole is also affiliated with Touro Infirmary. Dmand AI links Dr. Cole to 1 more hospital.
What medical group is Dr. John T. Cole part of?
Dr. Cole is linked to Ochsner Health. Dmand AI links Dr. Cole to 1 more medical group.
Does Dr. John T. Cole accept Medicare?
Yes. CMS data shows Dr. Cole billed Medicare for 325 services in 2024, and Dr. Cole accepts Medicare assignment.
Does Dr. John T. Cole offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Cole as offering telehealth services.
How many Medicare patients does Dr. John T. Cole see?
CMS counts 179 Medicare patients who saw Dr. Cole in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. John T. Cole bill to Medicare?
In 2024, Dr. Cole's most billed Medicare services were office visit, established patient (99213) and office visit, established patient (99214).
Where did Dr. John T. Cole go to medical school?
Dr. Cole graduated from Louisiana State University School of Medicine in New Orleans in 1981.
What drugs does Dr. John T. Cole prescribe most?
In 2024 Medicare Part D data, Dr. Cole's most prescribed drugs by claims were Letrozole, Anastrozole and Exemestane.
Has Dr. John T. Cole received payments from drug or device companies?
CMS Open Payments shows $1,786 in general payments to Dr. Cole from 16 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. John T. Cole been practicing?
Dr. Cole graduated from medical school in 1981, 45 years ago.
Does Dr. John T. Cole do research?
Dmand AI links 8 publications to Dr. Cole, published from 2012 to 2022. Dr. Cole has worked on 10 clinical trials.
Who does Dr. John T. Cole publish with?
Dr. Cole's most frequent co-authors are Jessica Marie Boyce, MD (1 shared paper), Fady Farag, MD (1 shared paper) and Yvonne E. Gilliland, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Louisiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card